Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nuchev Pty Ltd ( (AU:NUC) ) just unveiled an announcement.
Nuchev reported second-quarter FY26 group sales revenue of $5.3 million, down 19% quarter-on-quarter and 13% year-on-year, with steady performance in its core Oli6 retail business offset by a sharp 48% quarterly decline in practitioner-channel revenue amid softer trading conditions. Despite weaker international sales due to shipment timing and delayed launches, the company generated a net operating cash inflow of $0.8 million, ended the quarter with $3.1 million in cash and no debt, and highlighted new product development across both consumer and practitioner lines as a key driver for future portfolio expansion and scale in ANZ and overseas markets.
The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.13 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.
More about Nuchev Pty Ltd
Nuchev Limited is an Australian nutrition company focused on premium goat-based nutritional products, primarily marketed under its Oli6 brand through major grocery and pharmacy retailers such as Coles, Woolworths and Chemist Warehouse, and complemented by a practitioner-only portfolio distributed via its bWellness division across practitioner and specialty health channels in Australia and New Zealand, with a growing presence in selected international markets including Vietnam and China cross-border e-commerce.
Average Trading Volume: 15,979
Technical Sentiment Signal: Sell
Current Market Cap: A$21.17M
Learn more about NUC stock on TipRanks’ Stock Analysis page.